UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.498-503

2021

Volltextzugriff (PDF)

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.860-866

2020

Volltextzugriff (PDF)

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

European respiratory review, 2019-09, Vol.28 (153), p.190058

2019

Volltextzugriff (PDF)

Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma

Critical reviews in oncology/hematology, 2013-12, Vol.88 (3), p.477-493

2013

Volltextzugriff (PDF)

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.276-281

2014

Volltextzugriff (PDF)

MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort

Journal of thoracic oncology, 2008-04, Vol.3 (4), p.331-339

2008

Volltextzugriff (PDF)

Factors associated with long-term survival of patients with advanced non-small cell lung cancer

Respirology (Carlton, Vic.), 2012-01, Vol.17 (1), p.134-142

2012

Volltextzugriff (PDF)

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Clinical cancer research, 2015-04, Vol.21 (8), p.1896-1903

2015

Volltextzugriff (PDF)

Skin Toxicities Compromise Prolonged Pemetrexed Treatment

Journal of thoracic oncology, 2011-12, Vol.6 (12), p.2083-2089

2011

Volltextzugriff (PDF)

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes

JTO clinical and research reports, 2020-09, Vol.1 (3), p.100052-100052, Article 100052

2020

Volltextzugriff (PDF)

Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.1061-1063

2012

Volltextzugriff (PDF)

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1962-1967

2018

Volltextzugriff (PDF)

Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment

Journal of allergy and clinical immunology, 2008, Vol.121 (1), p.253-254

2008

Volltextzugriff (PDF)

Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?

Lung cancer (Amsterdam, Netherlands), 2021-02, Vol.152, p.94-97

2021

Volltextzugriff (PDF)

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2107-2116

2019

Volltextzugriff (PDF)

Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Carcinoma

Clinical lung cancer, 2016-07, Vol.17 (4), p.301-308

2016

Volltextzugriff (PDF)

Guidelines on smoking management during the perioperative period

Anaesthesia critical care & pain medicine, 2017-06, Vol.36 (3), p.195-200

2017

Volltextzugriff (PDF)

Factors associated with early progression of non‐small‐cell lung cancer treated by epidermal growth factor receptor tyrosine‐kinase inhibitors

Cancer medicine (Malden, MA), 2014-02, Vol.3 (1), p.61-69

2014

Volltextzugriff (PDF)

The advanced practice nurse in post-COViD-19 respiratory follow up

Soins; la revue de référence infirmière, 2021-03, Vol.66 (853), p.32

2021

Volltextzugriff (PDF)

Is chemotherapy rechallenge feasible in advanced-stage non-small-cell lung cancer?

Bulletin du cancer, 2019-09, Vol.106 (9), p.725-733

2019

Volltextzugriff (PDF)

Data from the AACR 2018 meeting on the combination chimio-immunotherapy on advanced non-small cells lung cancer (NSCLC)

Bulletin du cancer, 2018-10, Vol.105 (10), p.854

2018

Volltextzugriff (PDF)

EGFR and KRAS mutation status in non–small-cell lung cancer occurring in HIV-infected patients

Lung cancer (Amsterdam, Netherlands), 2016-06, Vol.96, p.74-77

2016

Volltextzugriff (PDF)

Alectinib in untreated anaplastic lymphoma kinase-positive non-small cell lung cancer

Annals of translational medicine, 2017-12, Vol.5 (23), p.460-460

2017

Volltextzugriff (PDF)

Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma

Bulletin du cancer, 2019-03, Vol.106 (3), p.179-188

2019

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(54)
Französisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Humans
(34)
Oncology
(31)
Life Sciences
(22)
Male
(20)
Female
(19)
Middle Aged
(18)
Respiratory System
(16)
Aged
(13)
Adult
(12)
Cancer
(12)
Lung Neoplasms - Drug Therapy
(10)
Lung Neoplasms - Pathology
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Carcinoma, Non-Small-Cell Lung - Pathology
(9)
Human Health And Pathology
(8)
Lung Neoplasms - Genetics
(8)
Non-Small Cell Lung Cancer
(8)
Carcinoma, Non-Small-Cell Lung - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung

MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort

Factors associated with long-term survival of patients with advanced non-small cell lung cancer

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Skin Toxicities Compromise Prolonged Pemetrexed Treatment

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes

Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment

Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial

Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Carcinoma

Guidelines on smoking management during the perioperative period

Factors associated with early progression of non‐small‐cell lung cancer treated by epidermal growth factor receptor tyrosine‐kinase inhibitors

The advanced practice nurse in post-COViD-19 respiratory follow up

Is chemotherapy rechallenge feasible in advanced-stage non-small-cell lung cancer?

Data from the AACR 2018 meeting on the combination chimio-immunotherapy on advanced non-small cells lung cancer (NSCLC)

EGFR and KRAS mutation status in non–small-cell lung cancer occurring in HIV-infected patients

Alectinib in untreated anaplastic lymphoma kinase-positive non-small cell lung cancer

Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma

Suchergebnisse filtern